In vitro efficacy of levonadifloxacin against methicillin-resistant Staphylococcus aureus (MRSA) including hVISA isolates collected across India
The present study demonstrated 100 % susceptibility to levonadifloxacin among the tested isolates of MRSA, highlighting its promising clinical potential for treating infections caused by this organism. Furthermore, the study recorded a concordance of 100 % between disc diffusion and Etest method with BMD, indicating the reliability of these methods.
Authors
- Kāmini Walia
- Sujatha Sistla (ORCID: https://orcid.org/0000-0002-4286-6908)
- Madhan Sugumar
- Meerabai Manoharan
- Sneha Vinayan
Institutions
- Indian Council of Medical Research (IN)
- Jawaharlal Institute of Post Graduate Medical Education and Research (IN)
Publication Details
- Journal
- Indian Journal of Medical Microbiology
- Published
- 2025-01-01
- DOI
- https://doi.org/10.1016/j.ijmmb.2025.100788
- Primary Topic
- Antimicrobial Resistance in Staphylococcus
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Jawaharlal Institute Of Postgraduate Medical Education and Research